American Money Management LLC Boosts Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

American Money Management LLC boosted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 15.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,408 shares of the healthcare conglomerate’s stock after buying an additional 326 shares during the period. American Money Management LLC’s holdings in UnitedHealth Group were worth $1,218,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of UNH. M&T Bank Corp boosted its holdings in UnitedHealth Group by 13.4% in the third quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock valued at $128,975,000 after purchasing an additional 26,074 shares during the last quarter. Sugarloaf Wealth Management LLC boosted its stake in shares of UnitedHealth Group by 17.6% in the fourth quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock worth $4,025,000 after buying an additional 1,193 shares during the last quarter. Benjamin Edwards Inc. raised its position in UnitedHealth Group by 1,275.3% during the third quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate’s stock valued at $26,060,000 after acquiring an additional 41,308 shares in the last quarter. Parsifal Capital Management LP purchased a new stake in UnitedHealth Group in the 3rd quarter worth approximately $21,165,000. Finally, Signal Advisors Wealth LLC increased its holdings in shares of UnitedHealth Group by 13.0% during the 4th quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock valued at $4,611,000 after purchasing an additional 1,051 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research firms have weighed in on UNH. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target on the stock in a research report on Friday, January 10th. Deutsche Bank Aktiengesellschaft upped their target price on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. Oppenheimer upped their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Finally, Stephens lifted their price target on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research note on Thursday, December 5th. Twenty analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $515.47 on Friday. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The company has a market cap of $471.51 billion, a price-to-earnings ratio of 33.26, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The stock’s 50-day moving average is $508.81 and its two-hundred day moving average is $544.24.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm’s revenue was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $5.83 EPS. Analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.63%. UnitedHealth Group’s payout ratio is currently 54.19%.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction that occurred on Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.33% of the stock is owned by company insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.